The genetics of Fuchs' corneal dystrophy

Expert Review of Ophthalmology

Volumn 7, Issue 4, 2012, Pages 363-375

  Iliff, Benjamin W ^a   Riazuddin, S Amer ^a   Gottsch, John D ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

cornea guttata; corneal endothelium; Descemet membrane; epithelial mesenchymal transition; FCD; Fuchs' corneal dystrophy; guttae; oxidative stress; unfolded protein

Indexed keywords

CLUSTERIN; TRANSCRIPTION FACTOR ZEB1; TRANSFORMING GROWTH FACTOR BETA1;

APOPTOSIS; AUTOSOMAL DOMINANT DISORDER; COLLAGEN VIII ALPHA 2 GENE; CONGENITAL CATARACT; CONGENITAL CORNEA DYSTROPHY; EDICT SYNDROME; EPITHELIAL MESENCHYMAL TRANSITION; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC LINKAGE; HEARING IMPAIRMENT; HUMAN; LOXHD1 GENE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHENOTYPE; PROTEIN FOLDING; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SLC4A11 GENE; SNOWFLAKE VITREORETINAL DEGENERATION; TCF4 GENE; TRANSFORMING GROWTH FACTOR BETA1 GENE; VITREORETINAL DEGENERATION; ZINC FINGER E BOX BINDING HOMEOBOX 1 GENE;

EID: 84866927599     PISSN: 17469899     EISSN: 17469902     Source Type: Journal    
DOI: 10.1586/eop.12.39     Document Type: Review

References (101)

1. Fuchs E. Dystrophia epithelialis corneae. Graefes. Arch. Clin. Exp. Ophthalmol. 76(3), 478-508 (1910).
2. Clegg JG. Diseases of the cornea: Remarks on dystrophies of the cornea and glaucoma, with especial reference to a familial ariety of the former. Trans. Ophthalmol. Soc. UK 35, 245-253 (1915).
3. Moeschler H. [Studies on pigmentation of the posterior corneal surface with 395 slit lamp microscope eye examinations of healthy individuals.] Z. Augenheilkd. 48, 195-202 (1922).
4. Cross HE, Maumenee AE, Cantolino SJ. Inheritance of Fuchs' endothelial dystrophy. Arch. Ophthalmol. 85(3), 268-272 (1971).
5. Vogt A. [Further results of slit lamp microscopy of the anterior segment of the eye.] Albrecht von Graefes Arch. Klin. Ophthalmol. 106, 63-103 (1921).
6. 467-472 1924
7. Graves B. Notes on microscopy of the living eye: Report of the Lang Clinical Research Scholarship, Royal London Ophthalmic Hospital. Br. J. Ophthalmol. 8(10), 467-472 (1924). 7 Friedenwald H, Friedenwald JS. Epithelial dystrophy of he cornea. Br. J. Ophthalmol. 9(1), 14-20 (1925).
8. Krachmer JH, Purcell JJ Jr, Young CW, Bucher KD. Corneal endothelial dystrophy: A study of 64 families. Arch. Ophthalmol. 96(11), 2036-2039 (1978). (Pubitemid 8404086)
9. Lorenzetti DW, Uotila MH, Parikh N, Kaufman HE. Central cornea guttata. Incidence in the general population. Am. J. Ophthalmol. 64(6), 1155-1158 (1967).
10. Zoega GM, Fujisawa A, Sasaki H et al. Prevalence and risk factors for cornea guttata in the Reykjavik Eye Study. Ophthalmology 113(4), 565-569 (2006).
11. Eghrari AO, McGlumphy EJ, Iliff BW et al. Prevalence and severity of Fuchs corneal dystrophy in tangier island. Am. J. Ophthalmol. 153(6), 1067-1072 (2012).
12. Kitagawa K, Kojima M, Sasaki H et al. Prevalence of primary cornea guttata and morphology of corneal endothelium in aging Japanese and Singaporean subjects. Ophthalmic Res. 34(3), 135-138 (2002). (Pubitemid 34827813)
13. Stocker FW. The endothelium of the cornea and its clinical implications. Trans. Am. Ophthalmol. Soc. 51, 669-786 (1953).
14. Doggart JH. Fuchs's epithelial dystrophy of the cornea. Br. J. Ophthalmol. 41(9), 533-540 (1957).
15. Louttit MD, Kopplin LJ, Igo RP Jr et al.; FECD Genetics Multi-Center Study Group. A multicenter study to map genes for Fuchs endothelial corneal dystrophy: baseline characteristics and heritability. Cornea 31(1), 26-35 (2012).
16. Iwamoto T, DeVoe AG. Electron microscopic studies on Fuchs' combined dystrophy: I. Posterior portion of the cornea. Invest. Ophthalmol. 10(1), 9-28 (1971).
17. Burns RR, Bourne WM, Brubaker RF. Endothelial function in patients with cornea guttata. Invest. Ophthalmol. Vis. Sci. 20(1), 77-85 (1981). (Pubitemid 11062154)
18. Wilson SE, Bourne WM, O'Brien PC, Brubaker RF. Endothelial function and aqueous humor flow rate in patients with Fuchs' dystrophy. Am. J. Ophthalmol. 106(3), 270-278 (1988).
19. Geroski DH, Matsuda M, Yee RW, Edelhauser HF. Pump function of the human corneal endothelium. Effects of age and cornea guttata. Ophthalmology 92(6), 759-763 (1985). (Pubitemid 15060003)
20. McCartney MD, Robertson DP, Wood TO, McLaughlin BJ. ATPase pump site density in human dysfunctional corneal endothelium. Invest. Ophthalmol. Vis. Sci. 28(12), 1955-1962 (1987). (Pubitemid 18019953)
21. McCartney MD, Wood TO, McLaughlin BJ. Moderate Fuchs' endothelial dystrophy ATPase pump site density. Invest. Ophthalmol. Vis. Sci. 30(7), 1560-1564 (1989). (Pubitemid 19185958)
22. Kopplin LJ, Przepyszny K, Schmotzer B et al.; Fuchs' Endothelial Corneal Dystrophy Genetics Multi-Center Study Group. Relationship of Fuchs endothelial corneal dystrophy severity to central corneal thickness. Arch. Ophthalmol. 130(4), 433-439 (2012).
23. Kayes J, Holmberg A. The fine structure of the cornea in Fuchs' endothelial dystrophy. Invest. Ophthalmol. 3, 47-67 (1964).
24. Sundin OH, Jun AS, Broman KW et al. Linkage of late-onset Fuchs corneal dystrophy to a novel locus at 13pTel- 13q12.13. Invest. Ophthalmol. Vis. Sci. 47(1), 140-145 (2006). (Pubitemid 46780806)
25. Sundin OH, Broman KW, Chang HH, Vito EC, Stark WJ, Gottsch JD. A common locus for late-onset Fuchs corneal dystrophy maps to 18q21.2-q21.32. Invest. Ophthalmol. Vis. Sci. 47(9), 3919-3926 (2006). (Pubitemid 46044307)
26. McGlumphy EJ, Yeo WS, Riazuddin SA et al. Age-severity relationships in families linked to FCD2 with retroillumination photography. Invest. Ophthalmol. Vis. Sci. 51(12), 6298-6302 (2010).
27. Riazuddin SA, Eghrari AO, Al-Saif A et al. Linkage of a mild late-onset phenotype of Fuchs corneal dystrophy to a novel locus at 5q33.1-q35.2. Invest. Ophthalmol. Vis. Sci. 50(12), 5667-5671 (2009).
28. Riazuddin SA, Zaghloul NA, Al-Saif A et al. Missense mutations in TCF8 cause late-onset Fuchs corneal dystrophy and interact with FCD4 on chromosome 9p. Am. J. Hum. Genet. 86(1), 45-53 (2010).
29. Krafchak CM, Pawar H, Moroi SE et al. Mutations in TCF8 cause posterior polymorphous corneal dystrophy and ectopic expression of COL4A3 by corneal endothelial cells. Am. J. Hum. Genet. 77(5), 694-708 (2005). (Pubitemid 41513274)
30. Afshari NA, Li YJ, Pericak-Vance MA, Gregory S, Klintworth GK. Genomewide linkage scan in Fuchs endothelial corneal dystrophy. Invest. Ophthalmol. Vis. Sci. 50(3), 1093-1097 (2009).
31. Li YJ, Minear MA, Rimmler J et al. Replication of TCF4 through association and linkage studies in late-onset Fuchs endothelial corneal dystrophy. PLoS ONE 6(4), e18044 (2011).
32. Mehta JS, Vithana EN, Tan DT et al. Analysis of the posterior polymorphous corneal dystrophy 3 gene, TCF8, in late-onset Fuchs endothelial corneal dystrophy. Invest. Ophthalmol. Vis. Sci. 49(1), 184-188 (2008).
33. Vincent AL, Niederer RL, Richards A, Karolyi B, Patel DV, McGhee CN. Phenotypic characterisation and ZEB1 mutational analysis in posterior polymorphous corneal dystrophy in a New Zealand population. Mol. Vis. 15, 2544-2553 (2009).
34. Yellore VS, Rayner SA, Nguyen CK et al. Analysis of the role of ZEB1 in the pathogenesis of posterior polymorphous corneal dystrophy. Invest. Ophthalmol. Vis. Sci. 53(1), 273-278 (2012).
35. Gottsch JD, Bowers AL, Margulies EH et al. Serial analysis of gene expression in the corneal endothelium of Fuchs' dystrophy. Invest. Ophthalmol. Vis. Sci. 44(2), 594-599 (2003). (Pubitemid 36159704)
36. Vithana EN, Morgan P, Sundaresan P et al. Mutations in sodium-borate cotransporter SLC4A11 cause recessive congenital hereditary endothelial dystrophy (CHED2). Nat. Genet. 38(7), 755-757 (2006). (Pubitemid 43980595)
37. Desir J, Moya G, Reish O et al. Borate transporter SLC4A11 mutations cause both Harboyan syndrome and non-syndromic corneal endothelial dystrophy. J. Med. Genet. 44(5), 322-326 (2007). (Pubitemid 46732626)
38. Vithana EN, Morgan PE, Ramprasad V et al. SLC4A11 mutations in Fuchs endothelial corneal dystrophy. Hum. Mol. Genet. 17(5), 656-666 (2008). (Pubitemid 351292255)
39. Riazuddin SA, Vithana EN, Seet LF et al. Missense mutations in the sodium borate cotransporter SLC4A11 cause late-onset Fuchs corneal dystrophy. Hum. Mutat. 31(11), 1261-1268 (2010).
40. Liu J, Seet LF, Koh LW et al. Depletion of SLC4A11 causes cell death by apoptosis in an immortalized human corneal endothelial cell line. Invest. Ophthalmol. Vis. Sci. 53(7), 3270-3279 (2012).
41. Riazuddin SA, Parker DS, McGlumphy EJ et al. Mutations in LOXHD1, a recessivedeafness locus, cause dominant late-onset Fuchs corneal dystrophy. Am. J. Hum. Genet. 90(3), 533-539 (2012).
42. Baratz KH, Tosakulwong N, Ryu E et al. E2-2 protein and Fuchs's corneal dystrophy. N. Engl. J. Med. 363(11), 1016-1024 (2010).
43. Riazuddin SA, McGlumphy EJ, Yeo WS, Wang J, Katsanis N, Gottsch JD. Replication of the TCF4 intronic variant in late-onset Fuchs corneal dystrophy and evidence of independence from the FCD2 locus. Invest. Ophthalmol. Vis. Sci. 52(5), 2825-2829 (2011).
44. Kuot A, Hewitt AW, Griggs K et al. Association of TCF4 and CLU polymorphisms with Fuchs' endothelial dystrophy and implication of CLU and TGFBI proteins in the disease process. Eur. J. Hum. Genet. 20(6), 632-638 (2012).
45. Thalamuthu A, Khor CC, Venkataraman D et al. Association of TCF4 gene polymorphisms with Fuchs' corneal dystrophy in the Chinese. Invest. Ophthalmol. Vis. Sci. 52(8), 5573-5578 (2011).
46. Tung PS, Burdzy K, Wong K, Fritz IB. Competition between cell-substratum interactions and cell-cell interactions. J. Cell. Physiol. 152(2), 410-421 (1992).
47. Jurkunas UV, Bitar MS, Rawe I, Harris DL, Colby K, Joyce NC. Increased clusterin expression in Fuchs' endothelial dystrophy. Invest. Ophthalmol. Vis. Sci. 49(7), 2946-2955 (2008).
48. Hirano K, Klintworth GK, Zhan Q, Bennett K, Cintron C. β Ig-h3 is synthesized by corneal epithelium and perhaps endotheliumin Fuchs' dystrophic corneas. Curr. Eye Res. 15(9), 965-972 (1996). (Pubitemid 26332236)
49. Munier FL, Korvatska E, Djemai A et al. Kerato-epithelin mutations in four 5q31-linked corneal dystrophies. Nat. Genet. 15(3), 247-251 (1997). (Pubitemid 27098716)
50. Jurkunas UV, Bitar M, Rawe I. Colocalization of increased transforming growth factor-β-induced protein (TGFBIp) and Clusterin in Fuchs endothelial corneal dystrophy. Invest. Ophthalmol. Vis. Sci. 50(3), 1129-1136 (2009).
51. Meadows DN, Eghrari AO, Riazuddin SA, Emmert DG, Katsanis N, Gottsch JD. Progression of Fuchs corneal dystrophy in a family linked to the FCD1 locus. Invest. Ophthalmol. Vis. Sci. 50(12), 5662-5666 (2009).
52. Biswas S, Munier FL, Yardley J et al. Missense mutations in COL8A2, the gene encoding the a2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophy. Hum. Mol. Genet. 10(21), 2415-2423 (2001). (Pubitemid 33069547)
53. Kobayashi A, Fujiki K, Murakami A et al. Analysis of COL8A2 gene mutation in Japanese patients with Fuchs' endothelial dystrophy and posterior polymorphous dystrophy. Jpn. J. Ophthalmol. 48(3), 195-198 (2004). (Pubitemid 38691425)
54. Mok JW, Kim HS, Joo CK. Q455V mutation in COL8A2 is associated with Fuchs' corneal dystrophy in Korean patients. Eye (Lond.) 23(4), 895-903 (2009).
55. Gottsch JD, Sundin OH, Liu SH et al. Inheritance of a novel COL8A2 mutation defines a distinct early-onset subtype of Fuchs corneal dystrophy. Invest. Ophthalmol. Vis. Sci. 46(6), 1934-1939 (2005).
56. Magovern M, Beauchamp GR, McTigue JW, Fine BS, Baumiller RC. Inheritance of Fuchs' combined dystrophy. Ophthalmology 86(10), 1897-1923 (1979).
57. Liskova P, Prescott Q, Bhattacharya SS, Tuft SJ. British family with early-onset Fuchs' endothelial corneal dystrophy associated with p.L450W mutation in the COL8A2 gene. Br. J. Ophthalmol. 91(12), 1717-1718 (2007). (Pubitemid 350207412)
58. Gottsch JD, Zhang C, Sundin OH, Bell WR, Stark WJ, Green WR. Fuchs corneal dystrophy: Aberrant collagen distribution in an L450W mutant of the COL8A2 gene. Invest. Ophthalmol. Vis. Sci. 46(12), 4504-4511 (2005). (Pubitemid 44264546)
59. Zhang C, Bell WR, Sundin OH et al. Immunohistochemistry and electron microscopy of early-onset Fuchs corneal dystrophy in three cases with the same L450W COL8A2 mutation. Trans. Am. Ophthalmol. Soc. 104, 85-97 (2006).
60. Jun AS, Broman KW, Do DV, Akpek EK, Stark WJ, Gottsch JD. Endothelial dystrophy, iris hypoplasia, congenital cataract, and stromal thinning (EDICT) syndrome maps to chromosome 15q22.1-q25.3. Am. J. Ophthalmol. 134(2), 172-176 (2002). (Pubitemid 34831819)
61. Akpek EK, Jun AS, Goodman DF, Green WR, Gottsch JD. Clinical and ultrastructural features of a novel hereditary anterior segment dysgenesis. Ophthalmology 109(3), 513-519 (2002). (Pubitemid 34184918)
62. Iliff BW, Riazuddin SA, Gottsch JD. A single-base substitution in the seed region of miR-184 causes EDICT syndrome. Invest. Ophthalmol. Vis. Sci. 53(1), 348-353 (2012).
63. Lee MM, Ritter R 3rd, Hirose T, Vu CD, Edwards AO. Snowflake vitreoretinal degeneration: Follow-up of the original family. Ophthalmology 110(12), 2418-2426 (2003). (Pubitemid 37485175)
64. Hejtmancik JF, Jiao X, Li A et al. Mutations in KCNJ13 cause autosomaldominant snowflake vitreoretinal degeneration. Am. J. Hum. Genet. 82(1), 174-180 (2008). (Pubitemid 351726076)
65. Nemoto S. Family cases of Harboyan syndrome. Jibiinkoka 58, 161-165 (1986). (Pubitemid 16164810)
66. Magli A, Capasso L, Foa T, Maurino V, Ventruto V. A further observation of corneal dystrophy and perceptive deafness in two siblings. Ophthalmic Genet. 18(2), 87-91 (1997). (Pubitemid 27338829)
67. Puga AC, Nogueira AH, Felix TM, Kwitko S. Congenital corneal dystrophy and progressive sensorineural hearing loss (Harboyan syndrome). Am. J. Med. Genet. 80(2), 177-179 (1998). (Pubitemid 28485701)
68. Abramowicz MJ, Albuquerque-Silva J, Zanen A. Corneal dystrophy and perceptive deafness (Harboyan syndrome): CDPD1 maps to 20p13. J. Med. Genet. 39(2), 110-112 (2002). (Pubitemid 34146379)
69. Park M, Li Q, Shcheynikov N, Zeng W, Muallem S. NaBC1 is a ubiquitous electrogenic Na+-coupled borate transporter essential for cellular boron homeostasis and cell growth and proliferation. Mol. Cell 16(3), 331-341 (2004). (Pubitemid 39504788)
70. Bibas A, Liang J, Michaels L, Wright A. The development of the stria vascularis in the human foetus. Clin. Otolaryngol. Allied Sci. 25(2), 126-129 (2000). (Pubitemid 30216125)
71. Creuzet S, Vincent C, Couly G. Neural crest derivatives in ocular and periocular structures. Int. J. Dev. Biol. 49(2-3), 161-171 (2005). (Pubitemid 40917336)
72. Morris KA, Snir E, Pompeia C et al. Differential expression of genes within the cochlea as defined by a custom mouse inner ear microarray. J. Assoc. Res. Otolaryngol. 6(1), 75-89 (2005). (Pubitemid 40616506)
73. Trune DR. Ion homeostasis in the ear: mechanisms, maladies, and management. Curr. Opin. Otolaryngol. Head Neck Surg. 18(5), 413-419 (2010).
74. Wangemann P. Supporting sensory transduction: Cochlear fluid homeostasis and the endocochlear potential. J. Physiol. (Lond.) 576(Pt 1), 11-21 (2006).
75. Lopez IA, Rosenblatt MI, Kim C et al. Slc4a11 gene disruption in mice: Cellular targets of sensorineuronal abnormalities. J Biol. Chem. 284(39), 26882-26896 (2009).
76. Grillet N, Schwander M, Hildebrand MS et al. Mutations in LOXHD1, an evolutionarily conserved stereociliary protein, disrupt hair cell function in mice and cause progressive hearing loss in humans. Am. J. Hum. Genet. 85(3), 328-337 (2009).
77. Edvardson S, Jalas C, Shaag A et al. A deleterious mutation in the LOXHD1 gene causes autosomal recessive hearing loss in Ashkenazi Jews. Am. J. Med. Genet. A 155A(5), 1170-1172 (2011).
78. Albin RL. Fuchs corneal dystrophy in a patient with mitochondrial DNA mutations. J. Med. Genet. 35(3), 258-259 (1998). (Pubitemid 28159936)
79. Stehouwer M, Bijlsma WR, Van der Lelij A. Hearing disability in patients with Fuchs' endothelial corneal dystrophy: unrecognized co-pathology? Clin. Ophthalmol. 5, 1297-1301 (2011).
80. McGowan SL, Edelhauser HF, Pfister RR, Whikehart DR. Stem cell markers in the human posterior limbus and corneal endothelium of unwounded and wounded corneas. Mol. Vis. 13, 1984-2000 (2007). (Pubitemid 350001954)
81. Eger A, Aigner K, Sonderegger S et al.ΔEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene 24(14), 2375-2385 (2005). (Pubitemid 40546696)
82. Sobrado VR, Moreno-Bueno G, Cubillo E et al. The class I bHLH factors E2-2A and E2-2B regulate EMT. J. Cell. Sci. 122(Pt 7), 1014-1024 (2009).
83. Ma C, Rong Y, Radiloff DR et al. Extracellular matrix protein βig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation. Genes Dev. 22(3), 308-321 (2008). (Pubitemid 351214273)
84. Chou TY, Chen WC, Lee AC, Hung SM, Shih NY, Chen MY. Clusterin silencing in human lung adenocarcinoma cells induces a mesenchymal-to-epithelial transition through modulating the ERK/Slug pathway. Cell. Signal. 21(5), 704-711 (2009).
85. Giese A, Bjerkvig R, Berens ME, Westphal M. Cost of migration: Invasion of malignant gliomas and implications for treatment. J. Clin. Oncol. 21(8), 1624-1636 (2003). (Pubitemid 46594118)
86. Grille SJ, Bellacosa A, Upson J et al. The protein kinase Akt induces epithelial-mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res. 63(9), 2172-2178 (2003). (Pubitemid 36538623)
87. Gupta A, Dey CS. PTEN and SHIP2 regulates PI3K/Akt pathway through focal adhesion kinase. Mol. Cell. Endocrinol. 309(1-2), 55-62 (2009).
88. Yu J, Peng H, Ruan Q, Fatima A, Getsios S, Lavker RM. MicroRNA-205 promotes keratinocyte migration via the lipid phosphatase SHIP2. FASEB J. 24(10), 3950-3959 (2010).
89. Gregory PA, Bert AG, Paterson EL et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 10(5), 593-601 (2008). (Pubitemid 351627379)
90. Korpal M, Lee ES, Hu G, Kang Y. The miR-200 family inhibits epithelial- mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J. Biol. Chem. 283(22), 14910-14914 (2008).
91. Borderie VM, Baudrimont M, Vallee A, Ereau TL, Gray F, Laroche L. Corneal endothelial cell apoptosis in patients with Fuchs' dystrophy. Invest. Ophthalmol. Vis. Sci. 41(9), 2501-2505 (2000). (Pubitemid 30624376)
92. Li Q J, Ashraf MF, Shen DF et al. The role of apoptosis in the pathogenesis of Fuchs endothelial dystrophy of the cornea. Arch. Ophthalmol. 119(11), 1597-1604 (2001). (Pubitemid 33035700)
93. Wang Z, Handa JT, Green WR, Stark WJ, Weinberg RS, Jun AS. Advanced glycation end products and receptors in Fuchs' dystrophy corneas undergoing Descemet's stripping with endothelial keratoplasty. Ophthalmology 114(8), 1453-1460 (2007). (Pubitemid 47126573)
94. Buddi R, Lin B, Atilano SR, Zorapapel NC, Kenney MC, Brown DJ. Evidence of oxidative stress in human corneal diseases. J. Histochem. Cytochem. 50(3), 341-351 (2002). (Pubitemid 34173022)
95. Jurkunas UV, Bitar MS, Funaki T, Azizi B. Evidence of oxidative stress in the pathogenesis of Fuchs endothelial corneal dystrophy. Am. J. Pathol. 177(5), 2278-2289 (2010).
96. Cadenas E, Davies KJ. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic. Biol. Med. 29(3-4), 222-230 (2000).
97. Dikstein S, Maurice DM. The metabolic basis to the fluid pump in the cornea. J. Physiol. (Lond.) 221(1), 29-41 (1972).
98. Jurkunas UV, Rawe I, Bitar MS et al. Decreased expression of peroxiredoxins in Fuchs' endothelial dystrophy. Invest. Ophthalmol. Vis. Sci. 49(7), 2956-2963 (2008).
99. Azizi B, Ziaei A, Fuchsluger T, Schmedt T, Chen Y, Jurkunas UV. p53-regulated increase in oxidative-stress-induced apoptosis in Fuchs endothelial corneal dystrophy: A native tissue model. Invest. Ophthalmol. Vis. Sci. 52(13), 9291-9297 (2011).
100. Engler C, Kelliher C, Spitze AR, Speck CL, Eberhart CG, Jun AS. Unfolded protein response in Fuchs endothelial corneal dystrophy: A unifying pathogenic pathway? Am. J. Ophthalmol. 149(2), 194.e2-202.e2 (2010).
101. Eghrari AO, Gottsch JD. Fuchs' corneal dystrophy. Expert Rev. Ophthalmol. 5(2), 147-159 (2010).